Page last updated: 2024-11-12

cefamandole nafate, monosodium salt, 14c-labeled, (6r-(6alpha,7beta,(r*)))-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cefamandole nafate: RN given refers to (6R-(6alpha,7beta(R*)))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cefamandole nafate : A cephalosporin prodrug having (R)-O-formylmandelamido and N-methylthiotetrazole side-groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16219159
MeSH IDM0311975

Synonyms (7)

Synonym
42540-40-9
cefamandole nafate
S3638
cefamandole nafate, european pharmacopoeia (ep) reference standard
cefamandole nafate, united states pharmacopeia (usp) reference standard
sodium (6r,7r)-7-(r)-mandelamido-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate formate (ester)
sodium;(6r,7r)-7-[[(2r)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (67.74)18.7374
1990's5 (16.13)18.2507
2000's3 (9.68)29.6817
2010's2 (6.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.39 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (22.86%)5.53%
Reviews0 (0.00%)6.00%
Case Studies4 (11.43%)4.05%
Observational0 (0.00%)0.25%
Other23 (65.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]